David S. Alberts, M.D., is a Professor of Medicine, Pharmacology and Public Health, the Director of Cancer Prevention and Control at the Arizona Cancer Center, and the Associate Dean for Research in the College of Medicine. He received his M.D. from the University of Virginia, Charlottesville, his internal medicine training at the University of Wisconsin and the University of Minnesota and his clinical pharmacology and medical oncology training at the National Cancer Institute (NCI) and the University of California, San Francisco. Dr. Alberts has been funded by the NCI yearly since 1975 for laboratory and clinical research related to the clinical pharmacology of cytotoxic and cancer preventive agents, as well as the development of research strategies for the prevention of breast, colon, prostate and skin cancers. He has been the Principal Investigator of university-wide, NCI-funded Skin and Colon Cancer Prevention Program Project grants since 1987. Dr. Alberts has authored or co-authored over 400 peer-reviewed journal articles and 80 book chapters and books on medical oncology and the clinical pharmacology of cytotoxic, biologic and chemopreventive agents. He is an Associate Editor of Cancer Research and Senior Editor of Cancer Epidemiology, Biomarkers and Prevention and serves as a member of the Scientific Advisory Board for the National Cancer Institute.

Susan Braun,

president and chief executive officer, joined the Susan G. Komen Breast Cancer Foundation in July 1996. She works together with the Foundation staff and Board of Directors to fulfill the organization’s mission: to eradicate breast cancer as a life-threatening disease by advancing research, education, screening and treatment. Her commitment to this mission is fueled by her professional background and her personal losses to breast cancer. Among her present appointments and responsibilities, Ms. Braun serves on leadership committees for several organizations, including: the National Action Plan on Breast Cancer, American Society of Clinical Oncology (international and health services research), American Society for Breast Disease (ASBD), World Society of Breast Health, Editorial Board of the Breast Journal, and Americorps NCCC. The Susan G. Komen Breast Cancer Foundation was established in 1982 by Nancy Brinker to honor the memory of her sister, Susan G. Komen, who died of breast cancer at the age of 36. From its inception through the end of fiscal year 1998, the Foundation has raised more than $214 million for breast cancer research, education, screening and treatment programs. The Foundation has more than 35,000 volunteers working through a network of U.S. and international Affiliates and Komen Race for the Cure® events to eradicate breast cancer as a life-threatening disease by advancing research, education, screening and treatment. The Foundation runs one of the most innovative, responsive grant programs in breast cancer today, having awarded more than $45 million in research grants since its inception. In addition to funding research, the Foundation and its Affiliates fund non-duplicative, community-based breast health education and breast cancer screening and treatment projects for the medically underserved. Prior to joining the Komen Foundation, Ms. Braun served in various positions within the Oncology/Immunology Division at Bristol-Myers Squibb in Princeton, New Jersey. Prior to joining Bristol-Myers Squibb, Ms. Braun was an executive with the health care consulting firm Pracon Incorporated and the Center for Economic Studies in Medicine. Ms. Braun received a bachelor’s degree in English and sociology from George Mason University and a master’s degree in health sciences from the University of Maryland. She also completed the graduate program in international marketing at the University of Muenster in Muenster, Germany.

Greta R. Bunin, Ph.D.,

is Research Associate Professor of Pediatrics, University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia, Philadelphia, PA. She received her Ph.D. in epidemiology from the University of California at Berheley. Dr. Bunin’s background includes serving as an epidemiologist at the Children’s Hospital of Philadelphia, Philadelphia, PA and as a Research Assistant professor of Pediatrics at the University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia, Philadelphia, PA. Dr. Bunin’s research focuses on the etiology of childhood cancer, particularly brain tumors. Among the risk factors of interest are maternal diet during pregnancy, parental occupational exposures, family history of cancer, polyomaviruses, household exposures and agricultural exposures. Another area of interest is investigating whether exposures can be identified that increase the risk of new germline mutations.

Donald S. Coffey, Ph.D.,

is a Professor of Urology, Oncology, Pathology and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine where he is also Director of the Research Laboratories of the Department of Urology. A prominent urological scientist, Dr. Coffey was appointed as The Catherine Iola and J. Smith Michael Distinguished Professor of Urology at the Johns Hopkins University School of Medicine. Dr. Coffey is also a member of the Principal Professional Staff at The Johns Hopkins University Applied Physics Laboratory. Dr. Coffey received his Ph.D. in Biochemistry from the Johns Hopkins University School of Medicine in 1964. Dr. Coffey is currently President-Elect of the National Coalition for Cancer Research. He is Past-President of the Society for Basic Urologic Research and the American Association for Cancer Research. For 19 years Dr. Coffey served as a member of the National Prostatic Cancer Program of the National Cancer Institute and served as National Chairperson from 1984-1988. He has received the Robert Edwards Award from The Tenovus Institute, the Fuller Award from the American Urological Association, and the First Society of International Urology - Yamanouchi Research Award. Dr. Coffey is also the recipient of two Merit Awards from the National Institutes of Health. He is an author on more than 250 research publications.

Robert DiPaola, M.D

., is the Associate Professor of Medicine and Executive Director of the Dean and Betty Gallo Prostate Cancer at the Cancer Institute of New Jersey. Dr. DiPaola received his M.D. from the University of Utah. He completed an internship and residency training at Duke University Medical Center, followed by an Oncology/Hematology fellowship at the University of Pennsylvania. Prior to taking his current position Dr. DiPaola worked as Associate Professor at The Cancer Institute of New Jersey. His primary research interests are breast and prostate cancers. Dr. DiPaola is a member of American Society of Clinical Oncology and American Association for Cancer Research. He is the author of numerous articles in the scientific literature covering various aspects of cancer research.

Sam Donaldson

is a veteran ABC journalist. He has been with the network since 1967. Mr. Donaldson currently is co-anchor of "PrimeTime Live" and is a regular on the Sunday show, "This Week," formerly known as "This Week with David Brinkley." Since beginning his ABC career as Capitol Hill correspondent, he has covered many major news stories, including the Vietnam War, Watergate, and the House Judiciary Committee impeachment investigation in 1974. From 1977 until 1989, Donaldson was ABC's chief White House correspondent. He was also anchor of "World News Sunday" from 1979 until 1989. His 1987 autobiography, "Hold On, Mr. President," was an international best seller. Donaldson has covered every national political convention since 1964 with the exception of the 1992 Republican Convention. For "PrimeTime Live" Donaldson has covered a wide variety of stories. During the 1994-95 season, he reported on one of the worst friendly fire accidents in U.S. history, which occurred over northern Iraq, killing 26 people. He investigated just what happened when two U.S. Air Force fighter plans shot down two U.S. Army helicopters, and, in an exclusive interview, spoke to the only man accused of making a mistake, Air Force Capt. Jim Wang, who later was acquitted of all charges. Among his stories for the 1992-93 season was one in which he investigated how for 40 years the six U.S. tobacco companies waged campaigns to obscure the truth about smoking hazards and fend off regulation. With "PrimeTime" live co-anchor Diane Sawyer, Donaldson joined President Bush and first lady Barbara Bush for a live tour of the first family's living quarters in 1989. They also co-anchored an unprecedented broadcast in 1990 from inside the Kremlin, where they toured its magnificent palaces and provided a rarely seen look at Lenin's private apartments. Donaldson also reported from Lockerbie, Scotland, in 1989 as part of an hour-long, award-winning investigation of the Pan Am 103 bombing. He was the first network television reporter to provide unilateral, live coverage from Saudi Arabia after the Iraqi invasion of Kuwait in 1990 and to provide unilateral, live coverage from Panama after the U.S. invasion in December 1989. Born in El Paso, Texas, Donaldson received a bachelor's degree from Texas Western College and did graduate work at the University of Southern California. Donaldson began his broadcast career at KRLD-TV in Dallas in 1959. He soon joined WTOP-TV in Washington, D.C., where he anchored the station's weekend news broadcasts and produced and moderated a weekly interview program before joining ABC News in 1967. He has received numerous awards, including three Emmys and a Peabody. The "Washington Journalism Review" named him the Best Television White House Correspondent in the Business in 1985, and the Best Television Correspondent in the Business for four consecutive years beginning in 1986.

Raymond N. DuBois, M.D., PhD

, is the Associate Director of the Vanderbilt-Ingram Cancer Center for Cancer Prevention and Director of Gastroenterology, Hepatology and Nutrition at the Vanderbilt University Medical Center. Dr. DuBois received his M.D. and Ph.D. degrees from the University of Texas Health Science Center Institutions at San Antonio and Dallas respectively. He completed an internship and residency training in Internal Medicine at The Johns Hopkins Hospital followed by a Gastroenterology fellowship at the same institution. He then obtained postdoctoral training as a Howard Hughes Research Associate in the Molecular Biology & Genetics Department at Johns Hopkins before taking a faculty position in the Departments of Medicine & Cell Biology at Vanderbilt University in 1991. His primary research interest is in the field of colorectal cancer prevention and pathogenesis. His laboratory has determined that the Cyclooxygenase-2 (COX-2) gene is elevated in human colorectal cancers and preclinical studies indicated that treatment with COX-2 inhibitors blocks tumor growth.Dr. DuBois has contributed to many textbooks and is on the editorial board of several research journals. He has published numerous journal articles, editorials and reviews and has been invited to present results of his work at several International meetings and Medical Centers. He is a member of several professional organizations, including the ASCI, AAP, AFMR, AACR, AGA and ASBMB. In recognition of his research in the Fall of 2000 he was inducted into the Royal College of Medicine by distinction.

Linda L. Frame, RN, MS, AOCN

is Senior Clinical Advisor at The Susan G. Komen Breast Cancer Foundation. As senior clinical advisor for the Susan G. Komen Breast Cancer Foundation, Linda Frame’s responsibilities include monitoring clinical issues and scientific developments in breast health and breast cancer, and keeping the Foundation current on medical, scientific and commercial advancements in the diagnosis, treatment and prevention of breast cancer. Ms. Frame also works closely with the Foundation’s cause-related marketing department to provide expert consultation to partners and sponsors who wish to develop in-house breast health education programs. As a registered nurse, Ms. Frame has been specializing in cancer for over 20 years. After completing a Masters of Science Degree in Nursing at Texas Women’s University, she received certification as an Advanced Oncology Certified Nurse. Prior to joining the Komen Foundation in 1992, Ms. Frame established and managed breast centers at several major hospitals in Texas. In addition to her nursing career, Ms. Frame served a total of 23 years in the Army Nurse Corps and the United States Army Reserves, retiring as a Lieutenant Colonel in 1992. Ms. Frame is a member of the Texas Nursing Association, Oncology Nursing Society and Sigma Theta Tau.

Joseph F. Fraumeni, M. D.,

is Director of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. Dr. Fraumeni received a B.A. from Harvard College, an M.D. from Duke University and an M.Sc. in Epidemiology from the Harvard School of Public Health. He completed his medical residency at Johns Hopkins Hospital and Memorial Sloan-Kettering Cancer Center. He came to the NCI in 1962 as a Staff Associate, becoming head of the Ecology Studies Section in 1966, Chief of the Environmental Epidemiology Branch in 1975, and Director of the Epidemiology and Biostatistics Program in 1979. In 1995, he was appointed Director of this division. His research of the environmental and genetic determinants of cancer has been recognized by the Lilienfeld Award from the American College of Epidemiology, the John Snow Award from the American Public Health Association, the James D. Bruce Award from the American College of Physicians, and the Charles S. Mott Prize from the General Motors Cancer Research Foundation. He was elected to the Institute of Medicine of the National Academy of Sciences and serves as Adjunct Professor of Epidemiology at the Harvard School of Public Health and the Uniformed Services University of the Health Sciences.

Gilbert H. Friedell

is Director Emeritus of the Markey Cancer Center and Professor of Pathology Emeritus at the University of Kentucky in Lexington. He has been involved for many years in the conduct of laboratory and clinical cancer research and in cancer control activities with particular emphasis on problems concerning cervical, breast, and urinary bladder cancer. . He was the Director of the National Cancer Institute National Bladder Cancer Project from 1971 to 1983, while also serving as the Chief of Pathology and then the Medical Director of a 600 bed community teaching hospital in Worcester, MA. After moving to Kentucky in 1983, Dr. Friedell became the founding director of the Kentucky Cancer Registry, the Principal Investigator of the NCI Mid-South Cancer Information Service, and Co-Director of a new statewide cancer control outreach program. From 1992 to 1999 he was Chair of the Steering Committee of the NCI Appalachia Leadership Initiative on Cancer. Since coming to Kentucky, his focus has mainly been on community cancer control activities in the medically underserved, rural population of Eastern Kentucky and Appalachia. He is also concerned about other health disparity populations and is a member of the Intercultural Cancer Council Governing Board. In 1998 he received both the National Humanitarian Award of the American Cancer Society and the Individual Community Service Award of the Susan G. Komen Foundation.

Curt Harris, M.D.,

is Chief of the Laboratory of Human Carcinogenesis and Head of its Molecular Genetics and Carcinogenesis Section. He also is a Clinical Professor of Medicine and Oncology at Georgetown University School of Medicine. Dr. Harris received his BA degree from Kansas University and his MD from Kansas University School of Medicine. He completed his clinical training in Internal Medicine at the University of California at Los Angeles and the National Cancer Institute. Dr. Harris has made outstanding scientific contributions to the fields of molecular carcinogenesis and molecular epidemiology of human cancer. He has received numerous honors throughout his distinguished career and according to ISI Science Watch, March 1998, is one of the 50 most cited biomedical scientists in the 1990's. Recent awards he has received include the Alton Ochsner Award relating Smoking and Health (American College of Physicians), Deichmann Award (International Union of Toxicology), Charles Heidelberger Award (International Society of Gastroenterological Carcinogenesis) and the Distinguished Service Medal, the highest honor of the U.S. Public Health Service. Dr. Harris has generated more than 400 journal publications, 100 book chapters, 10 books and 10 patents. He also serves as an Executive Editor for the journal, Carcinogenesis, and has held elected offices in scholarly societies including the American Association of Cancer Research and the International Society of Differentiation.

Kari Hemminki, M.D., PhD,

is a Professor of Epidemiology with a special reference to molecular epidemiology at the Karolinska Institute, Department of Bioseciences, Huddinge, Sweden. Dr. Hemminki received his M.D. degree and a Ph.D. in Medical Chemistry at the University of Helsinki in 1973. He continued his education as a post-doctoral fellow at the Johns Hopkins University, Department of Biology. His background includes serving as a research assistant and fellow at the University of Helsinki, Department of Medical Chemistry, and a temporary chief physician at the Institute of Occupational Health, Helsinki, Finland. He continued his research as a visiting scientist at the National Cancer Institute, Frederick Research Facility in Frederick, Maryland, Massachusetts Institute of Technology, Boston, Massachusetts, and at the Cambridge University, Institute of Public Health, United Kingdom. Dr. Hemminki has published numerous journal articles, editorials and reviews in both European and American scientific publications.

Brian Henderson, M.D.,

is a Professor of Preventive Medicine at the University of Southern California, Keck School of Medicine in Los Angeles, California. Dr. Henderson received his B. A. at the University of California in Berkeley and his M.D. degree at the University of Chicago in Chicago, Illinois. After completing his residency training in 1964 at the Massachusetts General Hospital in Boston, Massachusetts, he worked as a medical officer at the Center for Disease Control and Prevention in Atlanta, Georgia. Dr. Henderson established the Department of Preventive Medicine at Keck School of Medicine in 1978, later he served as Director of University of Southern California Norris Comprehensive Cancer Center in Los Angeles and as President and Professor of the Salk Institute for Biological Studies in La Jolla, California. He returned to his current position as a Professor of Preventive Medicine at the University of Southern California in 1994. Dr. Henderson’s primary research interests are the epidemiology and genetics of the hormone related cancers of the breast, prostate, ovary, testes and endomentrium. He is the Co-PI with Dr. Laurence Kolonel in Hawaii of a large Multi-ethnic long-term cohort study. Dr. Henderson has published numerous journal articles, editorials and reviews and has been the recipient of numerous awards. He received the Richard and Hinda Rosenthal Foundation Award and the Distinguished Service Award from University of Chicago in 1987, the Research Excellence in Cancer Epidemiology and Prevention Award in 1994. In 1999 he received the Presidential Medallion from the University of Southern California. Additionally, he is a member of the Institute of Medicine.

María A. Hernández-Valero, Dr.P.H.,

is Post-doctoral Fellow in the Department of Gynecologic Oncology, Division of Surgery at The University of Texas M.D. Anderson Cancer Center (MDACC), Houston, Texas. She received her Dr.P.H. degree from The University of Texas School of Public Health, Houston, Texas where she focused on hepatitis B and C prevention among Hispanic women and children. She earned an MA degree from Tulane University, New Orleans, LA where she focused on Latin American Culture, Linguistics and Literature. She also received an MS degree from The New School for Social Research, NYC, and in her thesis she compared occupationally related stress in minority populations. Her area of research concentrates in cancer prevention among minority populations, specifically the Hispanic sub-population of Mexican-American migrant farmworker (MFW) children. As a Post-Doctoral Fellow in the Department of Epidemiology (MDACC), Dr. Hernández-Valero conducted a pesticide exposure assessment among MFW families residing in the Houston Metropolitan Area, and detectable levels of several organochlorine pesticides were measured in MFW adults as well as children. Her interest in conducting research among MFW children is their vulnerability to potentially carcinogenic pesticides via multiple pathways (application drifts, carry-home exposures from parents, in utero exposure, lactation, and by going and/or working in the fields.

Richard Jackson, MD, MPH

is, currently, the Director of the National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention. During his tenure at NCEH, he as worked to increase support for stronger environmental health protection efforts throughout federal agencies, to engage CDC and local and state health departments in the genetics "revolution," and to increase efforts to improve the nutritional status of people in developing countries. In addition, Dr. Jackson is collaborating with groups and individuals from many disciplines—planners, architects, engineers, academicians, and policy makers—to explore the implications of urban sprawl on the nation’s environmental health. He received his baccalaureate degree from St. Peter’s College in Jersey City; a Master of Medical Sciences degree from Rutgers Medical School in New Brunswick; his M.D. from the University of California, San Francisco; and his M.P.H. in epidemiology from the University of California at Berkeley. Dr. Jackson authored many of the critical findings published in the National Academy of Sciences’ report titled Pesticides in the Diets of Infants and Children, a document which formed the basis of the nation’s 1996 Food Quality Protection Act that passed both houses of Congress unanimously. In addition, he serves on the editorial boards of two peer-reviewed medical journals and has published more than 30 refereed papers and several book chapters. Dr. Jackson has testified before U.S. Congressional committees on a variety of issues, including pesticides in the diets of infants and children, Gulf War Syndrome, and environmental health hazards to children, and has lectured throughout the world on environmental health issues. He serves on the Department of Health and Human Services’ (HHS) Environmental Health Policy Committee and is the HHS Senior Staff representative to the President’s Task Force on the Protection of Children from Environmental Health and Safety Risks.

Lovell Allan Jones, Ph.D.,

is presently a Professor in the Departments of Gynecologic Oncology and Biochemistry & Molecular Biology at the University of Texas M.D. Anderson Cancer Center (UTMDACC). Dr. Jones received his doctorate in 1977 in the field of zoology with an emphasis in endocrinology and tumor biology from the University of California, Berkeley. Since 1988, he has served as Director of the Experimental Gynecology/Endocrinology. In January 2000, he was named as the first Director of the Congressionally Mandated Center for Research on Minority Health. Since 1982, Dr. Jones has been a member of the graduate faculty at the University of Texas Graduate School for Biomedical Sciences. Dr. Jones has published over 100 scientific articles ranging from hormonal carcinogensis to health policy.

Woodie Kessel, M.D., M.P.H.,

is Assistant Surgeon General. For more than twenty years Dr. Kessel has been a public health professional and practitioner, advocate, and public policy leader on behalf of America’s children and families. Combining the disciplines of pediatrics, primary care, and public health, with first-hand experience in underserved inner-city urban communities, Dr. Kessel has championed the advancement of child health science, the prevention of illness, and the promotion of maternal and child health and well-being. Dr. Kessel has served with distinction as an officer in the United States Public Health Service attaining the rank of Assistant Surgeon General. He has been an advisor on child health matters to White House officials in four administrations, and throughout the Department of Health and Human Services directly serving seven Secretaries and five Surgeon Generals. Dr. Kessel is presently on special assignment serving as the Co-Director of the President’s Task Force on Environmental Health Risks and Safety Risks to Children. The Task Force, comprised of nine Cabinet Officials and seven White House Office Directors, is focusing on reducing asthma suffering, eliminating lead poisoning, preventing unintentional injuries from autos and bikes, preventing cancer from pesticides and other environmental exposures, and gaining a better understanding of what is harmful, harmless, and helpful to healthy growth and development throughout the life cycle.

Martha S. Linet, M.D.

, M.P.H., received an M.D. from Tufts University, and an M.P.H. from the Johns Hopkins School of Hygiene and Public Health. She is board certified in internal medicine and general preventive medicine, and is a Fellow of the American College of Epidemiology. Dr. Linet was an Associate Professor at Johns Hopkins before joining NCI as a Cancer Expert in 1987. Currently, she is Chief, Population Studies Section, Radiation Epidemiology Branch. Dr. Linet was elected to the American Epidemiological Society and to the Board of Directors of the American College of Epidemiology in 1999, where she also serves as Chair of the Publications Committee. Dr. Linet’s research focuses on: the potential role of non-ionizing radiation exposures from power lines and electrical appliances in relation to childhood leukemia, and wireless communication devices with brain tumors in adults. She also has conducted research on the relationship of specific medical conditions, surgical treatments, medications, and vaccinations to childhood and adult leukemias, lymphomas, and brain tumors; the association of radon, smoking, environmental chemical exposures, and infectious agents with childhood leukemia; and the quantitative estimation of occupational benzene exposure with risk of adult hematological malignancies and related disorders. Among Dr. Linet’s honors are the NIH Merit Award, the NIH Director’s Award, and the Henry L. Moses Award for outstanding clinical paper of 1997. Dr. Linet has long served as an advisor to the Leukemia Research Fund (London) and the European Institute of Oncology (Milan). She is a member of the Standing Committee on Epidemiology of the International Commission on Non-Ionizing Radiation Protection, the Advisory Group on Cancer and the Environment to the American Cancer Society, and the Committee on Environmental Health of the American Academy of Pediatrics. Dr. Linet authored the internationally recognized text The Leukemias: Epidemiologic Aspects.

John Milner, Ph.D.,

is a Professor in the Department of Nutrition at The Pennsylvania State University, where he is also Director of the Graduate Program in Nutrition. Dr. Milner is currently on an IPA at the National Cancer Institute where he is serving as the Chief Nutrition Science Research Group in the Division of Cancer Prevention. Dr. Milner is a member of several professional organizations, including the Institute of Food Technology, American Society for Nutritional Sciences, American Association of Cancer Research, American Society for Clinical Nutrition, and the American Chemical Society’s Food and Chemistry Division. He is a Fellow in the American Association for the Advancement of Science. He has served in an advisory capacity as a member of the U.S. Department of Agriculture’s Human Nutrition Board of Scientific Counselors, Joint USDA/HHS Dietary Guidelines Committee, and for the Food, Nutrition and Safety Committee within the International Life Sciences Institute. Dr. Milner has served as President of the American Society for Nutritional Sciences (formerly the American Institute of Nutrition) and has testified before the Subcommittee on Appropriations in Washington, D.C. and the Presidential Commission on Dietary Supplement Labels in Baltimore, Maryland. Dr. Milner has served as a member of the National Academy of Sciences Committee on Military Nutrition Research and is currently a member of the U.S. Olympic Committee Dietary Guidelines Task Force. Dr. Milner has published more than 260 abstracts, book chapters, and journal articles. He is a member of the editorial boards for the Journal of Medical Food, Journal of Nutritional Biochemistry and Nutrition and Cancer, An International Journal. His current research deals with the physiological importance of bioactive compounds in the diet on cancer risk. Much of his current research focuses on the anticancer properties of garlic and associated allyl sulfur compounds. Dr. Milner earned a Doctorate in Philosophy in nutrition, with a minor in biochemistry and physiology, from Cornell University and a Bachelor of Sciences in Animal Sciences from Oklahoma State University.

John D. Minna, M.D.

Currently: Professor of Internal Medicine and Pharmacology, Director Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX Undergraduate: Stanford University; Medical School: Stanford University Medical School; Internship and Residency in Internal Medicine: Massachusetts General Hospital, Boston, MA; 1969-1973 Research Associate, Laboratory of Biochemical Genetics, National Heart Lung and Blood Institute (NHLBI), NIH; 1973-1975 Head Section on Somatic Cell Genetics, LBG, NHLBI, NIH; Attending Physician, Clinical Center, NIH; 1975-1981 Chief NCI-VA and then 1981-1991, NCI-Navy Medical Oncology Branches, Division of Cancer Treatment (DCT), Clinical Oncology Program (COP), National Cancer Institute (NCI), Bethesda, MD; Professor of Internal Medicine, Uniformed Services University of the Health Sciences; Captain (ret), United States Public Health Service 1969-1991; 1991-1995 Director, Harold C. Simmons Cancer Center and Chief, Division of Medical Oncology and Hematology, UTSW Medical Center. 1995-present: Director, Nancy B. & Jake L. Hamon Center for Therapeutic Oncology Research, Director, W.A. "Tex" and Deborah Moncrief, Jr. Center for Cancer Genetics; Sarah M. & Charles E. Seay Distinguished Chair in Cancer Research; Max L. Thomas Distinguished Chair in Molecular Pulmonary Oncology. Member Board of Scientific Advisors (BSA), National Cancer Institute. Principal Investigator, NCI Lung Cancer Special Program of Research Excellence (SPORE) P50 grant.

Olufunmilayo (Funmi) Olopade, M.D.

is Associate Professor of Medicine and Director of the Center for Clinical Cancer Genetics. Dr. Olopade directs a multidisciplinary clinical and laboratory research program in cancer genetics at the University of Chicago Medical Center. This program helps speed the transfer of basic research in cancer genetics to the benefit of people. Dr. Olopade is an international leader in the emerging field of clinical cancer genetics- a field that seeks to identify and understand the various genes that contribute to cancer, how these genes interact with one another and how they are affected by environmental factors. Her current laboratory research is focused on tumor suppressor genes such as BRCA1 and BRCA2 that predispose to breast and ovarian cancers. As a Hematologist/Oncologist, Dr. Olopade specializes in the treatment of breast cancer. Dr. Olopade received her bachelor's and medical degrees with distinction from the University of Ibadan in her native Nigeria and served as a medical officer at the Nigerian Navy Hospital. She came to the United States as a resident in internal medicine at Cook County Hospital, Chicago where she was named Chief Medical Resident. She did her Hematology/Oncology Fellowship training at the University of Chicago and spent time studying molecular genetics of cancer under Dr. Janet Rowley, Blum-Riese Distinguished Service Professor of Medicine. A former James S. McDonnell Foundation Scholar and ASCO Young Investigator Awardee, Dr. Olopade currently is the Chairperson of the ASCO Task Force on Cancer Genetics education. Dr. Olopade has delivered over 100 lectures on topics including breast cancer, colon cancer and genetic testing. Her contributions to the professional literature include more than 100 articles, book chapters, and abstracts on topics including the genetics of cancer, and serving as a reviewer for several journals, including the Journal of Clinical Oncology and the New England Journal of Medicine.

John Edward Porter

is a partner in Hogan & Hartson's Washington, D.C. office and a member of the firm's Health group. Mr. Porter concentrates his practice on health law and education matters, including administrative and regulatory, international, legislative strategy, and education and health policy. Prior to joining Hogan and Hartson, Mr. Porter served twenty-one years as Congressman from Illinois' 10th District. In Congress he served on the Appropriations Committee, and as Chairman of the Subcommittee on Labor, Health and Human Services and Education; as Vice-Chairman of the Subcommittee on Foreign Operations; and as Vice-Chairman of the Subcommittee on Military Construction. Mr. Porter has been honored by many organizations for his work to balance the federal budget, protect the environment, promote human rights, and secure unprecedented funding increases for biomedical research through the National Institutes of Health. Mr. Porter was founder and co-chairman of the Congressional Human Rights Caucus, a voluntary association of over 250 Members of Congress working to identify, monitor and end human rights violations worldwide. He sponsored the legislation creating Radio Free Asia. He served as chairman of the Global Legislators Organized for a Balanced Environment (GLOBE USA), part of a world-wide network of parliamentarians (GLOBE International) working to coordinate efforts to protect the environment. A supporter of the arts and humanities, Mr. Porter served as a trustee of the John F. Kennedy Center for the Performing Arts. Before his election to Congress, Mr. Porter served in the Illinois House of Representatives from 1973 through 1979. He attended the Massachusetts Institute of Technology and received his undergraduate degree from Northwestern University. Following service in the U.S. Army, he graduated with distinction from the University of Michigan Law School where he was an editor of the law review, and then went on to serve as an Honor Law Graduate Attorney with the U.S. Department of Justice during the Kennedy administration. From 1963 to 1980, Mr. Porter practiced law in Evanston, Illinois. Mr. Porter is a member of a number of boards, including the Rand Corporation, PBS, Research! America, the Foundation for the National Institutes of Health, the Kemper Insurance Companies, and the Population Resource Center in Princeton, N.J.

Leslie Robison, Ph.D.,

is Associate Director for Prevention and Etiology, University of Minnesota Cancer Center. He is responsible for prevention and etiology activities. Dr. Robison received his Ph.D. from the University of Minnesota in 1982. Dr. Robison’s research is focused primarily on investigations relating to the cause and development of cancer in children, with a particular interest in childhood leukemia. Id addition, he is actively involved in the evaluation of Childhood cancer survivors to identify treatment-related late effects. An author and collaborator on more than 180 research papers, Dr. Robison is actively involved in Epidemiology and late Effects committee of the Children’s Oncology Group (COG), a network of institutions and investigators who identify and treat approximately 90% of all children with cancer in the United States. DR. Robison is the recipient of the Children’s Cancer Research Fund Endowed Chair in Pediatric Cancer from the University of Minnesota Cancer Center.

Steven A. Rosenberg, M.D., Ph.D.,

is Chief of Surgery at the National Cancer Institute in Bethesda, Maryland and a Professor of Surgery at the Uniformed Services University of Health Sciences and at the George Washington University School of Medicine and Health Sciences in Washington, D.C. Dr. Rosenberg received his B.A. and M.D. degree at The Johns Hopkins University in Baltimore, Maryland and a Ph.D. in Biophysics at Harvard University. After completing his residency training in surgery in 1974 at the Peter Bent Brigham Hospital in Boston, Massachusetts Dr. Rosenberg became the Chief of Surgery at the National Cancer Institute, a position he has held to the present time. Dr. Rosenberg has pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. He has also pioneered the development of gene therapy and was the first to successfully insert foreign genes into humans. He was the first to conduct studies of the gene therapy of cancer. More recently he and his group have cloned the genes encoding cancer regression antigens and have used these to develop cancer vaccines now being used to treat patients with metastatic melanoma. Dr. Rosenberg has been the recipient of numerous awards and is a member of the American Society of Clinical Oncology and served on its Board of directors. He is also a member of the Institute of Medicine of the National Academy of Sciences, the Society of University Surgeons, the American Surgical Association, the American Association for Cancer Research, and the American Association of Immunologist among others. Dr. Rosenberg is the author of over 787 articles in the scientific literature covering various aspects of cancer research and has authored 8 books. A study published by the Institute for Scientific Information in May 1999 revealed that Dr. Rosenberg was the most cited clinician in the world in the field of oncology for the 17 years between 1981 to 1998.

Margaret R. Spitz M.D. M.P.H.,

is chair of the Department of Epidemiology at The University of Texas M.D. Anderson Cancer Center. Dr. Spitz received her medical degree from the University of Witwatersrand Medical School in Johannesburg, South Africa and earned her master's of public health degree from The University of Texas School of Public Health in 1981. She was appointed the first permanent in May 1995. Nationally, Dr. Spitz serves on a National Institutes of Health (NIH) study section, on the Molecular Epidemiology Sub Committee of the Southwestern Oncology Group and on the external advisory committees of several major cancer centers. She is past- President of the American Society of Preventive Oncology. Her research focus is studying genetically determined susceptibility to carcinogenesis, with a major focus on smoking related malignancies. She is directing an NCI-funded case-control lung cancer study of cytogenetic and molecular determinants of tobacco susceptibility. Dr. Spitz also directs a case-control study of lung cancer in former smokers, evaluating susceptibility markers to tobacco carcinogenesis. She also serves as co-principal investigator of the Genetic Epidemiology Project in the Lung Cancer SPORE with The University of Texas Southwestern. Dr. Spitz is also funded to conduct a molecular epidemiologic study of environmental and genetic determinants of aggressive prostate cancer that includes anthropometric measurements and assessment of phytoestrogen intake. Her interactive research is further strengthened by active collaborations within a National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease in which she directs the Molecular Epidemiology Research Core. She is also a collaborator on an exciting initiative with a biotech company that is developing microarray technology to enable large scale and low cost genotyping with use of automated workstations for extracting DNA and performing DNA amplification, hybridization and detection.

Mary S. Wolff, Ph.D.,

is Professor in the Department of Community and Preventive Medicine with a joint appointment in the Derald H.Ruttenberg Cancer Center at the Mount Sinai School of Medicine in New York. She is Director of the Division of Environmental Health Science and of the Center for Children's Environmental Health and Disease Prevention Research, an NIEHS/EPA funded multidisciplinary research program. She received the B.A. degree from Welleseley College and the Ph.D. from Yale University, both in chemistry. She has served on NIOSH, DOD, and California Breast Cancer Research Program study sections, and chaired both DOD and California study sections. Dr. Wolff 's research interests focus upon the application of biological markers to determine human exposures to chemicals that occur in the environment and their relation to human health. She has been involved in numerous studies of persons exposed both occupationally and through the ambient environment to organochlorine pesticides and PCBs (polychlorinated biphenyls). Her research interests also include lead poisoning, dermal exposures, chemicals in breast milk, and the possible association of organochlorines to human cancer and reproductive dysfunction. Her current research focuses on breast cancer risk associated with environmental exposures and the genetic determinants of these risks, on genetic and environmental influences on reproductive development, and on dietary modulation of environmental exposures.David S. Alberts, M.D., is a Professor of Medicine, Pharmacology and Public Health, the Director of Cancer Prevention and Control at the Arizona Cancer Center, and the Associate Dean for Research in the College of Medicine. He received his M.D. from the University of Virginia, Charlottesville, his internal medicine training at the University of Wisconsin and the University of Minnesota and his clinical pharmacology and medical oncology training at the National Cancer Institute (NCI) and the University of California, San Francisco. Dr. Alberts has been funded by the NCI yearly since 1975 for laboratory and clinical research related to the clinical pharmacology of cytotoxic and cancer preventive agents, as well as the development of research strategies for the prevention of breast, colon, prostate and skin cancers. He has been the Principal Investigator of university-wide, NCI-funded Skin and Colon Cancer Prevention Program Project grants since 1987. Dr. Alberts has authored or co-authored over 400 peer-reviewed journal articles and 80 book chapters and books on medical oncology and the clinical pharmacology of cytotoxic, biologic and chemopreventive agents. He is an Associate Editor of Cancer Research and Senior Editor of Cancer Epidemiology, Biomarkers and Prevention and serves as a member of the Scientific Advisory Board for the National Cancer Institute.

Susan Braun,

president and chief executive officer, joined the Susan G. Komen Breast Cancer Foundation in July 1996. She works together with the Foundation staff and Board of Directors to fulfill the organization’s mission: to eradicate breast cancer as a life-threatening disease by advancing research, education, screening and treatment. Her commitment to this mission is fueled by her professional background and her personal losses to breast cancer. Among her present appointments and responsibilities, Ms. Braun serves on leadership committees for several organizations, including: the National Action Plan on Breast Cancer, American Society of Clinical Oncology (international and health services research), American Society for Breast Disease (ASBD), World Society of Breast Health, Editorial Board of the Breast Journal, and Americorps NCCC.  The Susan G. Komen Breast Cancer Foundation was established in 1982 by Nancy Brinker to honor the memory of her sister, Susan G. Komen, who died of breast cancer at the age of 36. From its inception through the end of fiscal year 1998, the Foundation has raised more than $214 million for breast cancer research, education, screening and treatment programs. The Foundation has more than 35,000 volunteers working through a network of U.S. and international Affiliates and Komen Race for the Cure® events to eradicate breast cancer as a life-threatening disease by advancing research, education, screening and treatment. The Foundation runs one of the most innovative, responsive grant programs in breast cancer today, having awarded more than $45 million in research grants since its inception. In addition to funding research, the Foundation and its Affiliates fund non-duplicative, community-based breast health education and breast cancer screening and treatment projects for the medically underserved. Prior to joining the Komen Foundation, Ms. Braun served in various positions within the Oncology/Immunology Division at Bristol-Myers Squibb in Princeton, New Jersey. Prior to joining Bristol-Myers Squibb, Ms. Braun was an executive with the health care consulting firm Pracon Incorporated and the Center for Economic Studies in Medicine. Ms. Braun received a bachelor’s degree in English and sociology from George Mason University and a master’s degree in health sciences from the University of Maryland. She also completed the graduate program in international marketing at the University of Muenster in Muenster, Germany.

Greta R. Bunin, Ph.D.,

is Research Associate Professor of Pediatrics, University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia, Philadelphia, PA. She received her Ph.D. in epidemiology from the University of California at Berheley. Dr. Bunin’s background includes serving as an epidemiologist at the Children’s Hospital of Philadelphia, Philadelphia, PA and as a Research Assistant professor of Pediatrics at the University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia, Philadelphia, PA. Dr. Bunin’s research focuses on the etiology of childhood cancer, particularly brain tumors. Among the risk factors of interest are maternal diet during pregnancy, parental occupational exposures, family history of cancer, polyomaviruses, household exposures and agricultural exposures. Another area of interest is investigating whether exposures can be identified that increase the risk of new germline mutations.

Donald S. Coffey, Ph.D.,

is a Professor of Urology, Oncology, Pathology and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine where he is also Director of the Research Laboratories of the Department of Urology. A prominent urological scientist, Dr. Coffey was appointed as The Catherine Iola and J. Smith Michael Distinguished Professor of Urology at the Johns Hopkins University School of Medicine. Dr. Coffey is also a member of the Principal Professional Staff at The Johns Hopkins University Applied Physics Laboratory. Dr. Coffey received his Ph.D. in Biochemistry from the Johns Hopkins University School of Medicine in 1964. Dr. Coffey is currently President-Elect of the National Coalition for Cancer Research. He is Past-President of the Society for Basic Urologic Research and the American Association for Cancer Research. For 19 years Dr. Coffey served as a member of the National Prostatic Cancer Program of the National Cancer Institute and served as National Chairperson from 1984-1988. He has received the Robert Edwards Award from The Tenovus Institute, the Fuller Award from the American Urological Association, and the First Society of International Urology - Yamanouchi Research Award. Dr. Coffey is also the recipient of two Merit Awards from the National Institutes of Health. He is an author on more than 250 research publications.

Robert DiPaola, M.D

., is the Associate Professor of Medicine and Executive Director of the Dean and Betty Gallo Prostate Cancer at the Cancer Institute of New Jersey. Dr. DiPaola received his M.D. from the University of Utah. He completed an internship and residency training at Duke University Medical Center, followed by an Oncology/Hematology fellowship at the University of Pennsylvania. Prior to taking his current position Dr. DiPaola worked as Associate Professor at The Cancer Institute of New Jersey. His primary research interests are breast and prostate cancers. Dr. DiPaola is a member of American Society of Clinical Oncology and American Association for Cancer Research. He is the author of numerous articles in the scientific literature covering various aspects of cancer research.

Sam Donaldson

is a veteran ABC journalist. He has been with the network since 1967. Mr. Donaldson currently is co-anchor of "PrimeTime Live" and is a regular on the Sunday show, "This Week," formerly known as "This Week with David Brinkley." Since beginning his ABC career as Capitol Hill correspondent, he has covered many major news stories, including the Vietnam War, Watergate, and the House Judiciary Committee impeachment investigation in 1974. From 1977 until 1989, Donaldson was ABC's chief White House correspondent. He was also anchor of "World News Sunday" from 1979 until 1989. His 1987 autobiography, "Hold On, Mr. President," was an international best seller. Donaldson has covered every national political convention since 1964 with the exception of the 1992 Republican Convention. For "PrimeTime Live" Donaldson has covered a wide variety of stories. During the 1994-95 season, he reported on one of the worst friendly fire accidents in U.S. history, which occurred over northern Iraq, killing 26 people. He investigated just what happened when two U.S. Air Force fighter plans shot down two U.S. Army helicopters, and, in an exclusive interview, spoke to the only man accused of making a mistake, Air Force Capt. Jim Wang, who later was acquitted of all charges. Among his stories for the 1992-93 season was one in which he investigated how for 40 years the six U.S. tobacco companies waged campaigns to obscure the truth about smoking hazards and fend off regulation.  With "PrimeTime" live co-anchor Diane Sawyer, Donaldson joined President Bush and first lady Barbara Bush for a live tour of the first family's living quarters in 1989. They also co-anchored an unprecedented broadcast in 1990 from inside the Kremlin, where they toured its magnificent palaces and provided a rarely seen look at Lenin's private apartments. Donaldson also reported from Lockerbie, Scotland, in 1989 as part of an hour-long, award-winning investigation of the Pan Am 103 bombing. He was the first network television reporter to provide unilateral, live coverage from Saudi Arabia after the Iraqi invasion of Kuwait in 1990 and to provide unilateral, live coverage from Panama after the U.S. invasion in December 1989. Born in El Paso, Texas, Donaldson received a bachelor's degree from Texas Western College and did graduate work at the University of Southern California. Donaldson began his broadcast career at KRLD-TV in Dallas in 1959. He soon joined WTOP-TV in Washington, D.C., where he anchored the station's weekend news broadcasts and produced and moderated a weekly interview program before joining ABC News in 1967. He has received numerous awards, including three Emmys and a Peabody. The "Washington Journalism Review" named him the Best Television White House Correspondent in the Business in 1985, and the Best Television Correspondent in the Business for four consecutive years beginning in 1986.

Raymond N. DuBois, M.D., PhD

, is the Associate Director of the Vanderbilt-Ingram Cancer Center for Cancer Prevention and Director of Gastroenterology, Hepatology and Nutrition at the Vanderbilt University Medical Center. Dr. DuBois received his M.D. and Ph.D. degrees from the University of Texas Health Science Center Institutions at San Antonio and Dallas respectively. He completed an internship and residency training in Internal Medicine at The Johns Hopkins Hospital followed by a Gastroenterology fellowship at the same institution. He then obtained postdoctoral training as a Howard Hughes Research Associate in the Molecular Biology & Genetics Department at Johns Hopkins before taking a faculty position in the Departments of Medicine & Cell Biology at Vanderbilt University in 1991. His primary research interest is in the field of colorectal cancer prevention and pathogenesis. His laboratory has determined that the Cyclooxygenase-2 (COX-2) gene is elevated in human colorectal cancers and preclinical studies indicated that treatment with COX-2 inhibitors blocks tumor growth.

Dr. DuBois has contributed to many textbooks and is on the editorial board of several research journals. He has published numerous journal articles, editorials and reviews and has been invited to present results of his work at several International meetings and Medical Centers. He is a member of several professional organizations, including the ASCI, AAP, AFMR, AACR, AGA and ASBMB. In recognition of his research in the Fall of 2000 he was inducted into the Royal College of Medicine by distinction.

Linda L. Frame, RN, MS, AOCN

is Senior Clinical Advisor at The Susan G. Komen Breast Cancer Foundation. As senior clinical advisor for the Susan G. Komen Breast Cancer Foundation, Linda Frame’s responsibilities include monitoring clinical issues and scientific developments in breast health and breast cancer, and keeping the Foundation current on medical, scientific and commercial advancements in the diagnosis, treatment and prevention of breast cancer. Ms. Frame also works closely with the Foundation’s cause-related marketing department to provide expert consultation to partners and sponsors who wish to develop in-house breast health education programs.

As a registered nurse, Ms. Frame has been specializing in cancer for over 20 years. After completing a Masters of Science Degree in Nursing at Texas Women’s University, she received certification as an Advanced Oncology Certified Nurse. Prior to joining the Komen Foundation in 1992, Ms. Frame established and managed breast centers at several major hospitals in Texas. In addition to her nursing career, Ms. Frame served a total of 23 years in the Army Nurse Corps and the United States Army Reserves, retiring as a Lieutenant Colonel in 1992.

Ms. Frame is a member of the Texas Nursing Association, Oncology Nursing Society and Sigma Theta Tau.

Joseph F. Fraumeni, M. D.,

is Director of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. Dr. Fraumeni received a B.A. from Harvard College, an M.D. from Duke University and an M.Sc. in Epidemiology from the Harvard School of Public Health. He completed his medical residency at Johns Hopkins Hospital and Memorial Sloan-Kettering Cancer Center. He came to the NCI in 1962 as a Staff Associate, becoming head of the Ecology Studies Section in 1966, Chief of the Environmental Epidemiology Branch in 1975, and Director of the Epidemiology and Biostatistics Program in 1979. In 1995, he was appointed Director of this division. His research of the environmental and genetic determinants of cancer has been recognized by the Lilienfeld Award from the American College of Epidemiology, the John Snow Award from the American Public Health Association, the James D. Bruce Award from the American College of Physicians, and the Charles S. Mott Prize from the General Motors Cancer Research Foundation. He was elected to the Institute of Medicine of the National Academy of Sciences and serves as Adjunct Professor of Epidemiology at the Harvard School of Public Health and the Uniformed Services University of the Health Sciences.

Gilbert H. Friedell

is Director Emeritus of the Markey Cancer Center and Professor of Pathology Emeritus at the University of Kentucky in Lexington. He has been involved for many years in the conduct of laboratory and clinical cancer research and in cancer control activities with particular emphasis on problems concerning cervical, breast, and urinary bladder cancer. . He was the Director of the National Cancer Institute National Bladder Cancer Project from 1971 to 1983, while also serving as the Chief of Pathology and then the Medical Director of a 600 bed community teaching hospital in Worcester, MA.

After moving to Kentucky in 1983, Dr. Friedell became the founding director of the Kentucky Cancer Registry, the Principal Investigator of the NCI Mid-South Cancer Information Service, and Co-Director of a new statewide cancer control outreach program. From 1992 to 1999 he was Chair of the Steering Committee of the NCI Appalachia Leadership Initiative on Cancer. Since coming to Kentucky, his focus has mainly been on community cancer control activities in the medically underserved, rural population of Eastern Kentucky and Appalachia. He is also concerned about other health disparity populations and is a member of the Intercultural Cancer Council Governing Board. In 1998 he received both the National Humanitarian Award of the American Cancer Society and the Individual Community Service Award of the Susan G. Komen Foundation.

Curt Harris, M.D.,

is Chief of the Laboratory of Human Carcinogenesis and Head of its Molecular Genetics and Carcinogenesis Section. He also is a Clinical Professor of Medicine and Oncology at Georgetown University School of Medicine.

Dr. Harris received his BA degree from Kansas University and his MD from Kansas University School of Medicine. He completed his clinical training in Internal Medicine at the University of California at Los Angeles and the National Cancer Institute.

Dr. Harris has made outstanding scientific contributions to the fields of molecular carcinogenesis and molecular epidemiology of human cancer. He has received numerous honors throughout his distinguished career and according to ISI Science Watch, March 1998, is one of the 50 most cited biomedical scientists in the 1990's. Recent awards he has received include the Alton Ochsner Award relating Smoking and Health (American College of Physicians), Deichmann Award (International Union of Toxicology), Charles Heidelberger Award (International Society of Gastroenterological Carcinogenesis) and the Distinguished Service Medal, the highest honor of the U.S. Public Health Service. Dr. Harris has generated more than 400 journal publications, 100 book chapters, 10 books and 10 patents. He also serves as an Executive Editor for the journal, Carcinogenesis, and has held elected offices in scholarly societies including the American Association of Cancer Research and the International Society of Differentiation.

Kari Hemminki, M.D., PhD,

is a Professor of Epidemiology with a special reference to molecular epidemiology at the Karolinska Institute, Department of Bioseciences, Huddinge, Sweden.

Dr. Hemminki received her M.D. degree and a Ph.D. in Medical Chemistry at the University of Helsinki in 1973. She continued her education as a post-doctoral fellow at the Johns Hopkins University, Department of Biology. Her background includes serving as a research assistant and fellow at the University of Helsinki, Department of Medical Chemistry, and a temporary chief physician at the Institute of Occupational Health, Helsinki, Finland. She continued her research as a visiting scientist at the National Cancer Institute, Frederick Research Facility in Frederick, Maryland, Massachusetts Institute of Technology, Boston, Massachusetts, and at the Cambridge University, Institute of Public Health, United Kingdom.

Dr. Hemminki has published numerous journal articles, editorials and reviews in both European and American scientific publications.

Brian Henderson, M.D.,

is a Professor of Preventive Medicine at the University of Southern California, Keck School of Medicine in Los Angeles, California.

Dr. Henderson received his B. A. at the University of California in Berkeley and his M.D. degree at the University of Chicago in Chicago, Illinois. After completing his residency training in 1964 at the Massachusetts General Hospital in Boston, Massachusetts, he worked as a medical officer at the Center for Disease Control and Prevention in Atlanta, Georgia. Dr. Henderson established the Department of Preventive Medicine at Keck School of Medicine in 1978, later he served as Director of University of Southern California Norris Comprehensive Cancer Center in Los Angeles and as President and Professor of the Salk Institute for Biological Studies in La Jolla, California. He returned to his current position as a Professor of Preventive Medicine at the University of Southern California in 1994. Dr. Henderson’s primary research interests are the epidemiology and genetics of the hormone related cancers of the breast, prostate, ovary, testes and endomentrium. He is the Co-PI with Dr. Laurence Kolonel in Hawaii of a large Multi-ethnic long-term cohort study.

Dr. Henderson has published numerous journal articles, editorials and reviews and has been the recipient of numerous awards. He received the Richard and Hinda Rosenthal Foundation Award and the Distinguished Service Award from University of Chicago in 1987, the Research Excellence in Cancer Epidemiology and Prevention Award in 1994. In 1999 he received the Presidential Medallion from the University of Southern California. Additionally, he is a member of the Institute of Medicine.

María A. Hernández-Valero, Dr.P.H.,

is Post-doctoral Fellow in the Department of Gynecologic Oncology, Division of Surgery at The University of Texas M.D. Anderson Cancer Center (MDACC), Houston, Texas. She received her Dr.P.H. degree from The University of Texas School of Public Health, Houston, Texas where she focused on hepatitis B and C prevention among Hispanic women and children. She earned an MA degree from Tulane University, New Orleans, LA where she focused on Latin American Culture, Linguistics and Literature. She also received an MS degree from The New School for Social Research, NYC, and in her thesis she compared occupationally related stress in minority populations. Her area of research concentrates in cancer prevention among minority populations, specifically the Hispanic sub-population of Mexican-American migrant farmworker (MFW) children. As a Post-Doctoral Fellow in the Department of Epidemiology (MDACC), Dr. Hernández-Valero conducted a pesticide exposure assessment among MFW families residing in the Houston Metropolitan Area, and detectable levels of several organochlorine pesticides were measured in MFW adults as well as children. Her interest in conducting research among MFW children is their vulnerability to potentially carcinogenic pesticides via multiple pathways (application drifts, carry-home exposures from parents, in utero exposure, lactation, and by going and/or working in the fields.

Richard Jackson, MD, MPH

is, currently, the Director of the National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention. During his tenure at NCEH, he as worked to increase support for stronger environmental health protection efforts throughout federal agencies, to engage CDC and local and state health departments in the genetics "revolution," and to increase efforts to improve the nutritional status of people in developing countries. In addition, Dr. Jackson is collaborating with groups and individuals from many disciplines—planners, architects, engineers, academicians, and policy makers—to explore the implications of urban sprawl on the nation’s environmental health. He received his baccalaureate degree from St. Peter’s College in Jersey City; a Master of Medical Sciences degree from Rutgers Medical School in New Brunswick; his M.D. from the University of California, San Francisco; and his M.P.H. in epidemiology from the University of California at Berkeley.

Dr. Jackson authored many of the critical findings published in the National Academy of Sciences’ report titled Pesticides in the Diets of Infants and Children, a document which formed the basis of the nation’s 1996 Food Quality Protection Act that passed both houses of Congress unanimously. In addition, he serves on the editorial boards of two peer-reviewed medical journals and has published more than 30 refereed papers and several book chapters.

Dr. Jackson has testified before U.S. Congressional committees on a variety of issues, including pesticides in the diets of infants and children, Gulf War Syndrome, and environmental health hazards to children, and has lectured throughout the world on environmental health issues. He serves on the Department of Health and Human Services’ (HHS) Environmental Health Policy Committee and is the HHS Senior Staff representative to the President’s Task Force on the Protection of Children from Environmental Health and Safety Risks.

Lovell Allan Jones, Ph.D.,

is presently a Professor in the Departments of Gynecologic Oncology and Biochemistry & Molecular Biology at the University of Texas M.D. Anderson Cancer Center (UTMDACC). Dr. Jones received his doctorate in 1977 in the field of zoology with an emphasis in endocrinology and tumor biology from the University of California, Berkeley. Since 1988, he has served as Director of the Experimental Gynecology/Endocrinology. In January 2000, he was named as the first Director of the Congressionally Mandated Center for Research on Minority Health. Since 1982, Dr. Jones has been a member of the graduate faculty at the University of Texas Graduate School for Biomedical Sciences. Dr. Jones has published over 100 scientific articles ranging from hormonal carcinogensis to health policy.

Martha S. Linet, M.D.

, M.P.H., received an M.D. from Tufts University, and an M.P.H. from the Johns Hopkins School of Hygiene and Public Health. She is board certified in internal medicine and general preventive medicine, and is a Fellow of the American College of Epidemiology. Dr. Linet was an Associate Professor at Johns Hopkins before joining NCI as a Cancer Expert in 1987. Currently, she is Chief, Population Studies Section, Radiation Epidemiology Branch. Dr. Linet was elected to the American Epidemiological Society and to the Board of Directors of the American College of Epidemiology in 1999, where she also serves as Chair of the Publications Committee. Dr. Linet’s research focuses on: the potential role of non-ionizing radiation exposures from power lines and electrical appliances in relation to childhood leukemia, and wireless communication devices with brain tumors in adults. She also has conducted research on the relationship of specific medical conditions, surgical treatments, medications, and vaccinations to childhood and adult leukemias, lymphomas, and brain tumors; the association of radon, smoking, environmental chemical exposures, and infectious agents with childhood leukemia; and the quantitative estimation of occupational benzene exposure with risk of adult hematological malignancies and related disorders. Among Dr. Linet’s honors are the NIH Merit Award, the NIH Director’s Award, and the Henry L. Moses Award for outstanding clinical paper of 1997. Dr. Linet has long served as an advisor to the Leukemia Research Fund (London) and the European Institute of Oncology (Milan). She is a member of the Standing Committee on Epidemiology of the International Commission on Non-Ionizing Radiation Protection, the Advisory Group on Cancer and the Environment to the American Cancer Society, and the Committee on Environmental Health of the American Academy of Pediatrics. Dr. Linet authored the internationally recognized text The Leukemias: Epidemiologic Aspects.

John Milner, Ph.D.,

is a Professor in the Department of Nutrition at The Pennsylvania State University, where he is also Director of the Graduate Program in Nutrition. Dr. Milner is currently on an IPA at the National Cancer Institute where he is serving as the Chief Nutrition Science Research Group in the Division of Cancer Prevention. Dr. Milner is a member of several professional organizations, including the Institute of Food Technology, American Society for Nutritional Sciences, American Association of Cancer Research, American Society for Clinical Nutrition, and the American Chemical Society’s Food and Chemistry Division. He is a Fellow in the American Association for the Advancement of Science.

He has served in an advisory capacity as a member of the U.S. Department of Agriculture’s Human Nutrition Board of Scientific Counselors, Joint USDA/HHS Dietary Guidelines Committee, and for the Food, Nutrition and Safety Committee within the International Life Sciences Institute. Dr. Milner has served as President of the American Society for Nutritional Sciences (formerly the American Institute of Nutrition) and has testified before the Subcommittee on Appropriations in Washington, D.C. and the Presidential Commission on Dietary Supplement Labels in Baltimore, Maryland. Dr. Milner has served as a member of the National Academy of Sciences Committee on Military Nutrition Research and is currently a member of the U.S. Olympic Committee Dietary Guidelines Task Force. Dr. Milner has published more than 260 abstracts, book chapters, and journal articles. He is a member of the editorial boards for the Journal of Medical Food, Journal of Nutritional Biochemistry and Nutrition and Cancer, An International Journal. His current research deals with the physiological importance of bioactive compounds in the diet on cancer risk. Much of his current research focuses on the anticancer properties of garlic and associated allyl sulfur compounds. Dr. Milner earned a Doctorate in Philosophy in nutrition, with a minor in biochemistry and physiology, from Cornell University and a Bachelor of Sciences in Animal Sciences from Oklahoma State University.

John D. Minna, M.D.

Currently: Professor of Internal Medicine and Pharmacology,

Director Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX Undergraduate: Stanford University; Medical School: Stanford University Medical School; Internship and Residency in Internal Medicine: Massachusetts General Hospital, Boston, MA; 1969-1973 Research Associate, Laboratory of Biochemical Genetics, National Heart Lung and Blood Institute (NHLBI), NIH; 1973-1975 Head Section on Somatic Cell Genetics, LBG, NHLBI, NIH; Attending Physician, Clinical Center, NIH; 1975-1981 Chief NCI-VA and then 1981-1991, NCI-Navy Medical Oncology Branches, Division of Cancer Treatment (DCT), Clinical Oncology Program (COP), National Cancer Institute (NCI), Bethesda, MD; Professor of Internal Medicine, Uniformed Services University of the Health Sciences; Captain (ret), United States Public Health Service 1969-1991; 1991-1995 Director, Harold C. Simmons Cancer Center and Chief, Division of Medical Oncology and Hematology, UTSW Medical Center. 1995-present: Director, Nancy B. & Jake L. Hamon Center for Therapeutic Oncology Research, Director, W.A. "Tex" and Deborah Moncrief, Jr. Center for Cancer Genetics; Sarah M. & Charles E. Seay Distinguished Chair in Cancer Research; Max L. Thomas Distinguished Chair in Molecular Pulmonary Oncology. Member Board of Scientific Advisors (BSA), National Cancer Institute. Principal Investigator, NCI Lung Cancer Special Program of Research Excellence (SPORE) P50 grant.

Olufunmilayo (Funmi) Olopade, M.D.

is Associate Professor of Medicine and Director of the Center for Clinical Cancer Genetics. Dr. Olopade directs a multidisciplinary clinical and laboratory research program in cancer genetics at the University of Chicago Medical Center. This program helps speed the transfer of basic research in cancer genetics to the benefit of people.

Dr. Olopade is an international leader in the emerging field of clinical cancer genetics- a field that seeks to identify and understand the various genes that contribute to cancer, how these genes interact with one another and how they are affected by environmental factors. Her current laboratory research is focused on tumor suppressor genes such as BRCA1 and BRCA2 that predispose to breast and ovarian cancers. As a Hematologist/Oncologist, Dr. Olopade specializes in the treatment of breast cancer.

Dr. Olopade received her bachelor's and medical degrees with distinction from the University of Ibadan in her native Nigeria and served as a medical officer at the Nigerian Navy Hospital. She came to the United States as a resident in internal medicine at Cook County Hospital, Chicago where she was named Chief Medical Resident. She did her Hematology/Oncology Fellowship training at the University of Chicago and spent time studying molecular genetics of cancer under Dr. Janet Rowley, Blum-Riese Distinguished Service Professor of Medicine. A former James S. McDonnell Foundation Scholar and ASCO Young Investigator Awardee, Dr. Olopade currently is the Chairperson of the ASCO Task Force on Cancer Genetics education.

Dr. Olopade has delivered over 100 lectures on topics including breast cancer, colon cancer and genetic testing. Her contributions to the professional literature include more than 100 articles, book chapters, and abstracts on topics including the genetics of cancer, and serving as a reviewer for several journals, including the Journal of Clinical Oncology and the New England Journal of Medicine.

John Edward Porter

is a partner in Hogan & Hartson's Washington, D.C. office and a member of the firm's Health group. Mr. Porter concentrates his practice on health law and education matters, including administrative and regulatory, international, legislative strategy, and education and health policy.

Prior to joining Hogan and Hartson, Mr. Porter served twenty-one years as Congressman from Illinois' 10th District. In Congress he served on the Appropriations Committee, and as Chairman of the Subcommittee on Labor, Health and Human Services and Education; as Vice-Chairman of the Subcommittee on Foreign Operations; and as Vice-Chairman of the Subcommittee on Military Construction. Mr. Porter has been honored by many organizations for his work to balance the federal budget, protect the environment, promote human rights, and secure unprecedented funding increases for biomedical research through the National Institutes of Health.

Mr. Porter was founder and co-chairman of the Congressional Human Rights Caucus, a voluntary association of over 250 Members of Congress working to identify, monitor and end human rights violations worldwide. He sponsored the legislation creating Radio Free Asia. He served as chairman of the Global Legislators Organized for a Balanced Environment (GLOBE USA), part of a world-wide network of parliamentarians (GLOBE International) working to coordinate efforts to protect the environment. A supporter of the arts and humanities, Mr. Porter served as a trustee of the John F. Kennedy Center for the Performing Arts.

Before his election to Congress, Mr. Porter served in the Illinois House of Representatives from 1973 through 1979. He attended the Massachusetts Institute of Technology and received his undergraduate degree from Northwestern University. Following service in the U.S. Army, he graduated with distinction from the University of Michigan Law School where he was an editor of the law review, and then went on to serve as an Honor Law Graduate Attorney with the U.S. Department of Justice during the Kennedy administration. From 1963 to 1980, Mr. Porter practiced law in Evanston, Illinois.

Mr. Porter is a member of a number of boards, including the Rand Corporation, PBS, Research! America, the Foundation for the National Institutes of Health, the Kemper Insurance Companies, and the Population Resource Center in Princeton, N.J.

Leslie Robison, Ph.D.,

is Associate Director for Prevention and Etiology, University of Minnesota Cancer Center. He is responsible for prevention and etiology activities. Dr. Robison received his Ph.D. from the University of Minnesota in 1982. Dr. Robison’s research is focused primarily on investigations relating to the cause and development of cancer in children, with a particular interest in childhood leukemia. Id addition, he is actively involved in the evaluation of Childhood cancer survivors to identify treatment-related late effects.

An author and collaborator on more than 180 research papers, Dr. Robison is actively involved in Epidemiology and late Effects committee of the Children’s Oncology Group (COG), a network of institutions and investigators who identify and treat approximately 90% of all children with cancer in the United States. DR. Robison is the recipient of the Children’s Cancer Research Fund Endowed Chair in Pediatric Cancer from the University of Minnesota Cancer Center.

Steven A. Rosenberg, M.D., Ph.D.,

is Chief of Surgery at the National Cancer Institute in Bethesda, Maryland and a Professor of Surgery at the Uniformed Services University of Health Sciences and at the George Washington University School of Medicine and Health Sciences in Washington, D.C.

Dr. Rosenberg received his B.A. and M.D. degree at The Johns Hopkins University in Baltimore, Maryland and a Ph.D. in Biophysics at Harvard University. After completing his residency training in surgery in 1974 at the Peter Bent Brigham Hospital in Boston, Massachusetts Dr. Rosenberg became the Chief of Surgery at the National Cancer Institute, a position he has held to the present time. Dr. Rosenberg has pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. He has also pioneered the development of gene therapy and was the first to successfully insert foreign genes into humans. He was the first to conduct studies of the gene therapy of cancer. More recently he and his group have cloned the genes encoding cancer regression antigens and have used these to develop cancer vaccines now being used to treat patients with metastatic melanoma. Dr. Rosenberg has been the recipient of numerous awards and is a member of the American Society of Clinical Oncology and served on its Board of directors. He is also a member of the Institute of Medicine of the National Academy of Sciences, the Society of University Surgeons, the American Surgical Association, the American Association for Cancer Research, and the American Association of Immunologist among others. Dr. Rosenberg is the author of over 787 articles in the scientific literature covering various aspects of cancer research and has authored 8 books. A study published by the Institute for Scientific Information in May 1999 revealed that Dr. Rosenberg was the most cited clinician in the world in the field of oncology for the 17 years between 1981 to 1998.

Margaret R. Spitz M.D. M.P.H.,

is chair of the Department of Epidemiology at The University of Texas M.D. Anderson Cancer Center. Dr. Spitz received her medical degree from the University of Witwatersrand Medical School in Johannesburg, South Africa and earned her master's of public health degree from The University of Texas School of Public Health in 1981. She was appointed the first permanent in May 1995. Nationally, Dr. Spitz serves on a National Institutes of Health (NIH) study section, on the Molecular Epidemiology Sub Committee of the Southwestern Oncology Group and on the external advisory committees of several major cancer centers. She is past- President of the American Society of Preventive Oncology. Her research focus is studying genetically determined susceptibility to carcinogenesis, with a major focus on smoking related malignancies. She is directing an NCI-funded case-control lung cancer study of cytogenetic and molecular determinants of tobacco susceptibility. Dr. Spitz also directs a case-control study of lung cancer in former smokers, evaluating susceptibility markers to tobacco carcinogenesis. She also serves as co-principal investigator of the Genetic Epidemiology Project in the Lung Cancer SPORE with The University of Texas Southwestern. Dr. Spitz is also funded to conduct a molecular epidemiologic study of environmental and genetic determinants of aggressive prostate cancer that includes anthropometric measurements and assessment of phytoestrogen intake. Her interactive research is further strengthened by active collaborations within a National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease in which she directs the Molecular Epidemiology Research Core. She is also a collaborator on an exciting initiative with a biotech company that is developing microarray technology to enable large scale and low cost genotyping with use of automated workstations for extracting DNA and performing DNA amplification, hybridization and detection.

Mary S. Wolff, Ph.D.,

is Professor in the Department of Community and Preventive Medicine with a joint appointment in the Derald H.Ruttenberg Cancer Center at the Mount Sinai School of Medicine in New York. She is Director of the Division of Environmental Health Science and of the Center for Children's Environmental Health and Disease Prevention Research, an NIEHS/EPA funded multidisciplinary research program. She received the B.A. degree from Welleseley College and the Ph.D. from Yale University, both in chemistry. She has served on NIOSH, DOD, and California Breast Cancer Research Program study sections, and chaired both DOD and California study sections. Dr. Wolff 's research interests focus upon the application of biological markers to determine human exposures to chemicals that occur in the environment and their relation to human health. She has been involved in numerous studies of persons exposed both occupationally and through the ambient environment to organochlorine pesticides and PCBs (polychlorinated biphenyls). Her research interests also include lead poisoning, dermal exposures, chemicals in breast milk, and the possible association of organochlorines to human cancer and reproductive dysfunction. Her current research focuses on breast cancer risk associated with environmental exposures and the genetic determinants of these risks, on genetic and environmental influences on reproductive development, and on dietary modulation of environmental exposures.